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LiverThe cell-toxic bile salt glycochenodeoxycholic acid (GCDCA) and taurochenodeoxycholic acid (TCDCA) are
responsible for hepatocyte demise in cholestatic liver diseases, while tauroursodeoxycholic acid (TUDCA) is
regarded hepatoprotective. We demonstrate the direct mitochondrio-toxicity of bile salts which deplete
the mitochondrial membrane potential and induce the mitochondrial permeability transition (MPT). The
bile salt mediated mechanistic mode of destruction signiﬁcantly differs from that of calcium, the prototype
MPT inducer. Cell-toxic bile salts initially bind to the mitochondrial outer membrane. Subsequently, the
structure of the inner boundary membrane disintegrates. And it is only thereafter that the MPT is induced.
This progressive destruction occurs in a dose- and time-dependent way. We demonstrate that GCDCA and
TCDCA, but not TUDCA, preferentially permeabilize liposomes containing the mitochondrial membrane protein
ANT, a process resembling theMPT induction inwholemitochondria. This suggests that ANT is one decisive target
for toxic bile salts. To our knowledge this is the ﬁrst report unraveling the consecutive steps leading to mitochon-
drial destruction by cell-toxic bile salts.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Mitochondria are critically involved in the induction of cell death.
A decisive event is the induction of the mitochondrial permeability
transition (MPT), an unspeciﬁc increase of the inner mitochondrial
membrane permeability up to 1.5 kDa. Upon MPT induction, a colloid-
osmotically driven inﬂux of water into the mitochondrial matrix
(“swelling”) occurs, causing mitochondrial structure changes [1], andr; Cyt C, cytochrome C; Cys A,
xy) phenyl-hydrazone; GCDCA,
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rights reserved.culminating in the distension and rupture of the outer membrane
(MOMP) [2–4]. MOMP liberates Cyt C into the cytosol, the hallmark
signal towards cell death [5–7]. In cell free systems, the MPT is typi-
cally assessed by an optical density (OD) decrease in mitochondrial
suspensions due to mitochondrial swelling, a direct consequence of
MPT induction.
Mechanistically theMPT is still a conundrum. Twomajormechanistic
MPT models, termed “classical” and “alternative” have been suggested.
The classical model claims a non-selective pore formed by proteins
from either the inner or both mitochondrial membranes [8,9]. However,
the molecular constituents of the MPT pore are still under debate
[5,6,9–11]. In contrast, the alternative model proposes denaturations/
rearrangements of membrane proteins to cause MPT [12]. At present, it
is also unclear whether theMPT, elicited by diverse stimuli, is mechanis-
tically a uniform process resulting in equally damaged mitochondria or
whether different stages of damage result from these stimuli. This ques-
tion is of particular importance with respect to the ongoing discussion
about the implication of the MPT in different cell death scenarios like
apoptosis or necrosis [5–7,13–17].
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the predominant hydrophobic bile salts accumulating in cholestatic
patients, and account for liver cell death [18–22]. Bile salt-dependent
mitochondrio-toxicity has been ﬁrmly established by several studiesTime [min]
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0 30 60 90 120[23], which have demonstrated that bile salts impair the inner mito-
chondrial transmembrane potential (MMP) [24] and induce the MPT
[24–26]. It remained, however, unclear how thismitochondrial destruc-
tion proceeds in detail, as such deleterious effects were especially
detected in the presence of markedly elevated calcium (e.g. 50 μM in
[24]), or with highly toxic doses of GCDCA [25,26].
In this report, we compared the mitochondrio-toxicity of GCDCA,
TCDCA, TUDCA and the “classical” MPT-inducer calcium. OD measure-
ments of mitochondrial suspensions demonstrate the MPT induction
upon cell toxic bile salt exposure. However, we ﬁnd that this approach
is of limited use in order to reveal the detailed sequence ofmitochondri-
al destruction elicited by GCDCA and TCDCA. We therefore concentrate
on an alternative approach, using zone electrophoresis in a free-ﬂow
device (ZE-FFE), in order to separate mitochondria with progressive
membrane damages, i.e., losses of outer membrane parts, upon bile
salt exposure [27,28]. We ﬁnd that bile salts initially bind to the mito-
chondrial outer membrane and mediate structural alterations of the
inner boundarymembrane, i.e., the innermembrane parts directly adja-
cent to the outer membrane. Subsequently, a signiﬁcant increase of the
inner membrane permeability irreversibly directs the mitochondria to-
wardsMPT andMOMP. As theseﬁndings point to a destructive progres-
sion of the bile salts via the mitochondrial membranes, we further
concentrated on the participation of twomajor abundantmitochondrial
proteins residing in the outer and inner mitochondrial membrane,
VDAC and ANT respectively. To that endwe employed dye-loaded lipo-
somes reconstituted with these proteins, which especially point to the
inner membrane protein ANT to mediate the process of toxic bile salt
derived mitochondrial destruction. To our knowledge, this is the ﬁrst
report, which dissects themitochondrial destruction into deﬁned stages
upon direct exposure to cell-toxic bile salts in the patho-physiological
concentration range. This study may therefore serve as a blueprint for
the elucidation ofmitochondrio-toxic events elicited by other patholog-
ical situations or chemical exposures.
2. Material and methods
2.1. Mitochondrial analyses
Fresh rat liver mitochondria were essentially isolated as described
elsewhere [29]. In brief, cell debris of homogenized rat liver tissue was
removed by two consecutive centrifugations (800 × g, 10 min each).
Thereafter, mitochondria were pelleted from the supernatant
(9000 × g, 10 min), further puriﬁed by Percoll™ density gradient cen-
trifugation (9000 × g, 10 min), subsequently washed and ﬁnally
pelleted at 9000 × g [29]. Isolated mitochondria were subjected to
quantiﬁcation and kept on ice until use. Membrane potential (MMP)
was monitored by the rhodamine 123 quenching method at Ex 485/
20 nm, Em 528/20 nm [30] in 96-well plates containing 3 mg/ml fresh-
ly isolated mitochondria in a Synergy2 plate reader (BioTek, Bad
Friedrichshall, Germany). FCCP (1 μM) served as internal control for
MMP dissipation. MPT-induction was followed by light scattering at
540 nm in 1 min intervals for 2 h under the same conditions as for
MMP. Parallel monitoring of MMP–MPT (Fig. 2) was done as above in
the same wells. Measuring intervals were 1 min 13 s with 31 s delays
for MPT and MMP measurements. In control experiments indepen-
dence of both assessed parameters was validated. Results were directly
exported into Excel to display the respective MMP/MPT curves (Fig. 1,
S1, 2A–C upper panels, S2A–E upper panels).Fig. 1. Pharmacological interventions demonstrate the mechanistic difference of calcium
and bile salt mediated MPT. Optical density measurements (OD540 nm) of freshly isolated
rat liver mitochondria incubated with buffer (control), 100 μM calcium or 500 μM bile
salts (control: n = 7, Ca2+: n = 6, GCDCA: n = 5, TCDCA: n = 3, TUDCA: n = 4) and
co-incubated with either 5 μM Cys A (control: n = 3, Ca2+: n = 6, GCDCA: n = 5,
TCDCA: n = 3, TUDCA: n = 4), or 1 μM FCCP (control: n = 9, Ca2+: n = 7, GCDCA:
n = 9, TCDCA: n = 6, TUDCA: n = 2), or 500 μMMβCD (n = 4), or upon amitochondri-
al calcium preload (20 μM; GCDCA: n = 5, TCDCA and TUDCA: n = 3).
2123S. Schulz et al. / Biochimica et Biophysica Acta 1828 (2013) 2121–21332.2. Zone electrophoresis in a free-ﬂow device
Zone electrophoresis in a free ﬂow electrophoresis device (ZE-FFE) is
an adequate tool for the puriﬁcation and preparative analysis of mito-
chondria isolated from various sources, such as yeast, plants or liver tis-
sues [31–34]. In ZE-FFE, charged particles are injected into a laminar
buffer stream, deﬂected by a perpendicular oriented electrical ﬁeld, and
collected at the end of the separation chamber [27]. As themitochondrial
inner membrane from rat liver mitochondria differs in surface charge
from the enveloping outer membrane [27,28,35], ZE-FFE can detect
whether mitochondria have undergone an MPT-induced MOMP, due to
the resulting exposure of more negative inner membrane charges
[27,28]. The more the outer membrane is stripped off by MPT from the
mitochondria, the more the resulting remnants shift towards the anode
[27,28]. Here we used this approach to separate bile salt treated mito-
chondria that have undergone actual MPT with MOMP, from mitochon-
dria with an intact outer membrane.
Freshly isolated rat liver mitochondria were challenged with
500 μM GCDCA, TCDCA, or TUDCA as indicated in Figs. 3, S3 and 4.
Reference ZE-FFE proﬁles were buffer or calcium (100 μM) treated
mitochondria; 10 min incubation time each. Subsequently mitochondria
were pelleted, resuspended in separation buffer and subjected to ZE-FFE
at the cathodal side with a sample ﬂow rate of 1–2 ml/h. Electrophoresis
was performed at 750 V in horizontal mode at 4 °C as described in detail
elsewhere [27,31,34,36]. Mitochondrial populations were collected
in 96-well plates and separation was followed at 260 nm in a plate
reader (μQuant, BioTek, Bad Friedrichshall, Germany) [36]. Results
were directly exported into Excel to display the separation proﬁles,
wherein fraction 1 is most anodal and fraction 96 cathodal. For the
sake of clarity, the deﬂection ranges of the mitochondrial populations
are displayed (fraction 40 to 60). Peak fractions were collected for fur-
ther analysis.
2.3. ANT-isolation from rat hearts
ANT was isolated essentially as described [37] using mitochondria
puriﬁed by differential centrifugation from four rat hearts each.
Mitochondria were solubilised with 6% Triton X-100 and supernatants
loaded on hydroxyapatite columns (BioRad, Munich, Germany),
eluted and diluted with low concentration (0.5%) Triton X-100 buffer
and further puriﬁed by a “HiTrapSP” cation exchanger column (GE
Healthcare, Munich, Germany), linked to a FPLC system. ANT was eluted
by a 0–1 MNaCl gradient and FPLC fractions were analyzed for ANT con-
tent by immunoblot analysis and checked for purity/cross-contamination
with VDAC.
2.4. VDAC-isolation from rat liver
VDAC was isolated according to de Pinto et al. [38]. Rat liver
mitochondria were solubilised with 3% Triton X-100 followed by a
1 h ultracentrifugation at 100,000 ×g. Supernatants were puriﬁed
by a hydroxyapatite:celite®535 column (2:1) (BioRad, Munich, and
Roth, Karlsruhe, Germany). VDAC was eluted with 0.5% Triton
X-100, pH 7.0. Eluate fractions were checked for VDAC content and
ANT cross-contamination by immunoblot analysis.
2.5. ANT and VDAC reconstitution in liposomes and test assay
Liposome preparation and protein reconstitution into liposomes
were done as described [39]. As phosphatidylcholine, phosphatidyletha-
nolamine and phosphatidylinositol aremajor phospholipid species in rat
liver mitochondrial membranes [40,41] we used a soybean extract
(Sigma, Munich, Germany), enriched in L-α-phosphatidylcholine
(14–23%) but also containing phosphatidylethanolamine and phos-
phatidylinositol in order to roughly mimic these mitochondrial
membrane constituents. While this composition neglects the speciﬁcpresence of cholesterol and cardiolipin in the mitochondrial outer and
inner membranes, respectively, we have chosen this identical phospho-
lipid composition for the reconstituted proteoliposomes in order
to limit the experimental differences to the embedded membrane
proteins. The approximated fatty acid composition includes 20% palmitic,
5% stearic, 10% oleic, 59% linoleic and 7% linolenic acids (Sigma, Munich,
Germany). The soybean extract was dissolved in chloroform, nitrogen
dried and resuspended under agitation. 3 ml of solution was incubated
for 20 min with either 3 ml of 125 mM sucrose, 10 mM HEPES, pH 7.4
(liposomes), 3 ml of ANT or 3 ml of VDAC (ANT- or VDAC-
proteoliposomes), respectively. Liposomes and proteoliposomes were
dialysed over night, aliquoted and either stored at −80 °C or imme-
diately tested for their sensitivities towards bile salts. Thereto
4-methylumbelliferyl phosphate (4-MUP) was entrapped in liposomes
and proteoliposomes by soniﬁcation upon residual dye removal by a
Sephadex G25 column (GE Healthcare, Munich, Germany). Sensitivity
against 1 to 2 h challenges of GCDCA, TCDCA, or TUDCA was assessed
by dye release from the liposomes/proteoliposomes, detected after
enzymatic conversion using alkaline phosphatase (Roche, Mannheim,
Germany) by ﬂuorescence (Ex: 360/40 nm, Em: 460/40 nm) in a Syner-
gy2 plate reader (BioTek, Bad Friedrichshall, Germany). Datawere direct-
ly exported to Excel. Self-ﬂuorescence of GCDCA, TCDCA, and TUDCAwas
subtracted from ﬂuorescence values of liposomes/proteoliposomes.
Triton X-100 was used to determine maximal dye release.
2.6. Miscellaneous
Protein quantiﬁcations were done by the Bradford assay. Immuno-
blotting was done according to Ref. [42]. Blots were digitalized with a
GS-710 Calibrated Imaging Densitometer (BioRad, Munich, Germany).
Blots (Fig. S5) and displayed sections (Figs. 3, 4 and S4) were adjusted
for brightness, contrast, and black/white balance by Adobe Photoshop
CS3 Extended. Electron microscopy of the mitochondrial populations
was done as previously described [27] on a Zeiss EM 10 CR electron
microscope with the Soft Imaging Viewer (Olympus Soft Imaging
Solutions GmbH, Münster, Germany). Micrographs were adjusted for
brightness, contrast, and black/white balance by Adobe Photoshop
CS3 Extended. Detection of mitochondrial bound bile salts by gas
chromatography was done as previously described [43].
2.7. Statistics
Statistics were performed in Excel using t-test. Data were tested
unpaired and two-tailed. Differences were denoted statistically signiﬁ-
cant with * = p b 0.05, ** = p b 0.01, *** = p b 0.001.
3. Calculation
3.1. Parameter deﬁnition for quantitative MPT and MMP comparison
For the quantitative comparison of the mitochondrial responses to
toxic bile salt challenge in terms of MPT- and MMP-measurements, we
deﬁned threshold parameters for MPT and MMP-loss start and ﬁnish
time points. We calculated the slopes of MPT- and MMP-measurement
curves, using the “gradient” option of the software MATLAB. For
smoothing, averages of slope values were calculated for each data
point using the preceding and subsequent data points. Corresponding
slope proﬁles are displayed directly below the MMP/MPT curves
(cf. Fig. 2A–C, and Fig. S2A–E). Based on the slopes of buffer treated
control mitochondria, we deﬁned the thresholds for MPT and
MMP-loss start and ﬁnish. Here we determined a slope ≥1 for the
beginning of MMP loss and a slope of b−0.003 for swelling/MPT
start. The reverse values marked the end of these processes. Based
on the start, end and slope values, we quantitatively determined
the duration of the MMP-loss/MPT processes, as well as the time
points when these processes become maximal (i.e. maximal slopes).
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slopes (boxes) were subsequently determined from the curve slopes
by the “ﬁndpeaks” option in MATLAB. Results were displayed by the
“plot” and “bar” options of MATLAB (cf. Figs. 2A–C lower panels,
S2A–E lower panels 2D, and S2F respectively). The bar lengths depict
the duration of the MPT (solid line) and MMP-loss (dashed line),
respectively.
This approach offers two main advantages. First, compared to the
measured curves, the slope proﬁles better visualize the kinetics of the
MMP-loss and MPT (cf. Fig. 2A–C). Second, this curve sketchingFig. 2. Bile salts paradoxically inverseMMP-loss andMPT-induction. Simultaneousmeasureme
liver mitochondria upon bile salt challenges in comparison to calcium. A–C MMP and MPT me
n = 7, GCDCA: n = 5, TCDCA: n = 8. D Bar charts of MMP/MPT double measurements. Bar l
points; boxes signify inﬂection points. Ca2+: n = 7 (100 μM), GCDCA: n = 5 (500 μM), TCDCenables a quantitative analysis of the MMP/MPT in a time dependent
fashion.
4. Results
4.1. Bile salt mediated direct mitochondrio-toxicity differs from calcium
dependent impairment
In chronic cholestasis, hepatocytes die upon elevated levels of the
toxic bile salts GCDCA and TCDCA [44], which can reach intracellularnts of MPT induction (OD540 nm) andMMP loss (Rh123 ﬂuorescence) of freshly isolated rat
asurement curves (upper panels) with their corresponding slopes (lower panels). Ca2+:
ength depicts MPT and MMP loss duration, respectively. Triangles indicate start and end
A: n = 8 (500 μM), GCDCA and TCDCA: n = 6 (250 μM), n = 5 (125 μM).
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involving mitochondria, as upon incubation, exposed hepatocytes lose
their MMP [43]. Freshly isolated rat liver mitochondria undergo the
MPT upon exposure to cell-toxic bile salts at pathological relevant con-
centrations ranging from 125 μM to 500 μM, with GCDCA being more
toxic than TCDCA (Fig. 1, Fig. S1A, B). Moreover, upon co-incubation
with low-dose calcium (20 μM), the GCDCA or TCDCA-induced MPT
rate is drastically accelerated, pointing out to a synergistic deleterious
effect of bile salts and calcium on mitochondria (Fig. 1). TUDCA does
not elicit the MPT (Fig. 1). A calcium/TUDCA co-incubation is identical
to the delayed MPT onset elicited by 20 μM calcium alone (Fig. 1). We
therefore askedwhether bile salts and calciumattack themitochondrial
membranes via the same molecular mechanism or whether their dele-
terious action can be distinguished experimentally. For this purpose, we
tested the effects of Cys A, an inhibitor of calcium-induced MPT [47],
FCCP, which destroys the MMP, thereby avoiding calcium uptake and
MPT-induction, and MβCD, which is known to bind bile salts (Fig. 1).
Both Cys A and FCCP abolish calcium-induced MPT, but only
decelerate GCDCA or TCDCA induced swelling (Fig. 1). On the contrary,
MβCD has no inﬂuence on calcium-inducedMPT, but delays GCDCA- or
TCDCA-provoked MPT in a dose dependent fashion (Fig. 1, Fig. S1C, D).
TUDCA does not elicit the MPT (Fig. 1). Thus, the bile salts inducedMPT
differs mechanistically from the calcium-elicited MPT.
4.2. Toxic bile salts paradoxically inverse MMP-depletion and MPT-onset
As FCCP instantly destroys the MMP [48], but retards the MPT onset
evoked by bile salts, we further investigated the relation between MPT
induction and MMP-loss.
Mitochondrial suspensions were challenged by either high dose
calcium or varying doses of bile salts. MMP and MPT were simulta-
neously assessed from the same samples (Fig. 2). The upper panels
of Fig. 2A–C display MMP (Rh123 ﬂuorescence) and MPT (OD540 nm)
curves. We aimed at a quantitative comparison of these mitochondrial
responses in a time-dependent fashion. Therefore, we calculated the
corresponding slope proﬁles of the MMP and MPT curves, respectively
(displayed directly below the MMP/MPT curves, Fig. 2A–C, andFig. S2A–E). This approach offers several advantages. First, compared
to the measured curves, the slope proﬁles better visualize the kinetics
of the MMP-loss and MPT (Fig. 2A–C). Second, based on the slopes of
buffer treated control mitochondria, it allows deﬁning thresholds for
starting and end points of MMP-loss and MPT. Here we determined a
slope ≥1 for the beginning of MMP loss and a slope of b−0.003 for
swelling/MPT start. The reverse valuesmarked the end of these processes.
Third, based on the start, end and slope values, one can quantitatively
determine the duration of the MMP-loss/MPT processes, as well as the
time points when these processes become maximal (Fig. 2D). Thus, this
curve sketching enables a quantitative analysis of the MMP/MPT in a
time dependent fashion.
This analysis veriﬁed that calcium causes the instant and almost si-
multaneous onset of both swelling and MMP-loss, whereby MMP-loss
ﬁnishes slightly before MPT (05:22 ± 02:49 vs. 08:10 ± 02:36 min,
Fig. 2D). Thus, upon calcium challenge, the MMP-loss precedes the MPT.
High dose GCDCA (500 μM) gives a similar result (Fig. 2D). TUDCA
remains non-toxic in all experiments (data not shown).
TCDCA and lower concentrations of GCDCA (250/125 μM) cause an
instant drop inOD540 nm, indicative of immediatemitochondrial swelling.
Surprisingly, however, the MMP-loss is postponed in a concentration-
dependent manner (Figs. 2C, D, S2A–D). Thus, under these conditions, it
seems that the MPT precedes the MMP-loss.
This initial drop in OD540 nm upon exposure to cell-toxic bile salt
presents a clear paradox. Upon initiation of MPT, i.e., inner membrane
permeabilization, a rapid passage of protons across the IM occurs,
causing the MMP to instantaneously drop to zero [9]. At this point a
reconsideration of the biophysical characteristics of the MPT assay
merits attention. Mitochondrial suspensions are turbid and scatter
light [48]. Upon MPT induction, mitochondria swell and thereby
change their diffraction properties causing decreased light scattering,
measured as a decline in OD540 nm [48]. However, as this MPT assay
basically assesses the optical density of a mitochondrial suspension
in total, any (structure changing) process, that signiﬁcantly affects
the mitochondrial diffraction index will cause an altered OD. Thus,
this assay does not only detect MPT. It therefore appears possible,
that the initial OD drop upon bile salt exposure reﬂects mitochondrial
2126 S. Schulz et al. / Biochimica et Biophysica Acta 1828 (2013) 2121–2133structure changes rather than immediate MPT-induction, since MMP
is initially retained.
This hypothesis is further supported by the fact that upon TCDCA
and lower concentrations of GCDCA, the elicited MPT/swelling process
becomes two-phased (e.g., Fig. 2C). A fast but limited decline in
OD540 nm is followed by a slower but more pronounced swelling
(Fig. 2C MPT curve), which is clearly apparent in the corresponding
slope proﬁle (Fig. 2C MPT slope). It is known that upon induction of the
MPT the volume change for the individual mitochondrion is an
“all-or-nothing event” [49], and that the OD540 nm changes reﬂect the
volume change of the fraction of mitochondria that have undergone
the MPT [49]. Thus, the observed two-phased OD540 nm changes could
be due to two OD changing processes, of which only the later one is
the MPT. The fact that there is no MMP loss concomitantly occurring
with the initial OD540 nm changes supports this conclusion.
Upon MMP depletion with FCCP, the swelling process induced by
500 μM GCDCA is massively prolonged but not inhibited (Fig. S2E).
As with TCDCA, and in contrast to 500 μM GCDCA alone, the swelling
process is two-phased (Fig. S2F). Especially, the second phase of
swelling, i.e., the supposed actual MPT, indicated by the second inﬂec-
tion point, is strongly postponed (Fig. S2F).
It therefore appears that bile salts induce a complex pattern of
molecular events in mitochondria which lead to alterations in their
OD. It further appears that the “classical” swelling assay is only of limited
use to characterize these events.
4.3. Bile salts alter inner-mitochondrial structures culminating in
membrane damage
As the combined MMP/MPT analysis suggested that cell-toxic bile
salts alter mitochondria before initiating the MPT, and as these events
can only unsatisfactorily be resolved by optical density measurements,
we employed an alternative methodological approach:
The outer membrane rupture/permeabilization (MOMP) is the
deﬁned endpoint of the MPT [16]. Especially in liver mitochondria,
the MPT-induced MOMP results in inner membrane vesicles (IMVs
or “mitoplasts”) [49,50]. IMVs are highly negatively charged particles
which can electrophoretically be distinguished and separated from
intact mitochondria [27,28,35], i.e., from mitochondria that have not
undergone MOMP. We therefore used an electrophoretic approach
(zone electrophoresis in a free ﬂow device, ZE-FFE) to separate bile salt
treated mitochondria that have undergone actual MPT with MOMP
(i.e., IMVs), from mitochondria with an intact outer membrane.
As previously reported [27,31], intactmitochondria incubated either
in test buffer alone (control) or additionally with the non-toxic TUDCA,
gather in one major peak (Fig. 3A, B). In contrast, mitochondria treated
with 100 μM calcium or 500 μM GCDCA immediately undergo MPT
(Figs. 1, 2), which result in IMVs that signiﬁcantly deﬂect towards the
anode (Fig. 3C, D). This anodal shift is thus associated with MOMP, as
also evidenced by a marked depletion of the outer membrane protein
VDAC (Fig. 3F). As expected, FCCP treated mitochondria do not shift
towards the anode upon calcium challenge, fully in agreement with a
blocked MPT (Fig. S3B). MβCD/Ca2+ treated mitochondria, however, do
so (Fig. S3C), conﬁrming that MβCD does not inhibit the Ca2+-induced
MPT (Fig. 1).
Unlike calcium and 500 μM GCDCA, a 10 min TCDCA challenge
causes several prominent peaks (Fig. 3E). Here, the broader cathodal
peak contains an additional anodal shoulder peak, indicating the
emergence of distinct mitochondrial subpopulations, as conﬁrmed
by electron microscopy (Fig. 3E). The most cathodal mitochondria
possess a seemingly intact outer membrane, yet exhibit signiﬁcant
cristae remodeling (Fig. 3E-III). This ﬁnding proves our above conclu-
sion that mitochondrial structure alterations other than MPT-induced
MOMP occur upon TCDCA treatment. TCDCA mitochondria gathering
in the anodal shoulder peak demonstrate a heterogeneous picture
(Fig. 3E-II); and TCDCA mitochondria from the major anodal peakhave an IMV structure, and therefore, are mitochondria that have un-
dergone MPT/MOMP (Fig. 3E-I).
Furthermore, when the MPT-onset induced by GCDCA is delayed
by FCCP or MβCD (Fig. 1), mitochondria with modiﬁed structures
but present outer membrane are observed (Fig. S3D-II, E-II). These
organelles are collected from a major but barely shifted peak (Fig.
S3D, E). Thus, although the electrophoretic characteristics of these
mitochondria have barely changed, their intra-mitochondrial structure
clearly has (Fig. S3D-II, E-II). Moreover, as shown in Fig. S3D-II, a struc-
tural transition can be observed even within single mitochondria. Here,
parts with normal structure coexist with altered parts (Fig. S3D-II). This
suggests that these alterations represent an early stage of bile salt in-
ducedmitochondrial destruction, and that the IMV structures do appear
at a later stage.
4.4. Successive events of TCDCA induced mitochondrial toxicity
In order to demonstrate that the structurally altered, but MOMP-
negative, mitochondria (Figs. 3E-III, S3D-II and S3E-II) do represent
earlier stages of a continuous destruction process that ﬁnally leads to
IMVs (Figs. 3E-I, S3D-I and S3E-I), we followed the TCDCA-dependent
effects on mitochondria by a time resolved ZE-FFE approach.
In contrast to intact mitochondria (Fig. 4-I, II), a 5 min TCDCA treat-
ment already results in two subpopulations, one major barely shifted
peak and one smaller more anodal peak (Fig. 4-III, IV). The mitochon-
dria of the barely shifted peak retained their outer membranes, yet
show beginning cristae remodeling (Fig. 4-IV). This is even more pro-
nounced in mitochondria collected from the anodal peak (Fig. 4-III). In
addition, in these mitochondria, the inner boundary membrane has
largely disappeared (Fig. 4-III) and the mitochondria appear larger in
size, an indication of a commencing mitochondrial swelling (Fig. 4-III).
As incubation time increases, the major peaks progressively deﬂect to-
wards the anode, (Fig. 4, 10 to 40 min). This is paralleled by cristae re-
modeling, retraction of the inner boundary membrane and IMV
formation (Fig. 4).
We subsequently analyzed these mitochondrial subpopulations
for outer membrane integrity. Loss of Cyt C is a hallmark signal for cell
death induction and VDAC depletion unequivocally demonstrates
MOMP (immunoblot in Fig. 4). All anodal shifted subpopulations of
TCDCA treated mitochondria demonstrate a pronounced Cyt C loss
(Fig. 4 III, V, VII and VIII). In addition, a progressive VDAC depletion
paralleled the extent of shift towards the anode (Fig. 4 II = IV ≤
VI b V ≤ III/VIII b VII). Interestingly, a slightly higher Cyt C loss was
noted in subpopulation VI compared to the similarly deﬂecting sub-
population IV. However, in these both subpopulations, VDAC levels
remained relatively unchanged at the level of control mitochondria.
This clearly suggests that small outer membrane permeabilities
occur in subpopulation VI which are sufﬁcient for a partial Cyt C loss.
Taken together these analyses demonstrate the time-dependent
progression of mitochondrial destruction by TCDCA. The electron
micrographs of Fig. 4 II→ IV→ VI→ VIII→ X (right column) visualize
this sequential process. Starting from intact mitochondria (II), an imme-
diate rearrangement of the cristae near by the outer membrane occurs
(IV). This progressively worsens and is associated with a disappearance
of the inner boundary membrane and with a partial Cyt C release (VI).
Subsequently, severe mitochondrial damages occur (VIII), and it is only
then that mitochondria lose their MMP (see time axis in Fig. 2D) and
actually undergo MPT. Massive matrix rearrangements take place (VIII),
which are accompanied by a profound Cyt C release and MOMP (immu-
noblot in Fig. 4). Eventually, largely IMVs are present (X), marking the
end stage of the MPT.
4.5. The mitochondrial target structures for cell toxic bile salts
From the above observations, twomajor bile salt-induced damaging
events can be distinguished. An initial structure change near the outer
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the inner boundary membrane, is followed by MMP-loss and the MPT.
As bile salts cause these profound mitochondrial membrane
changes, it seems reasonable to assume that a sufﬁciently strongTable 1
Binding of bile salts to mitochondria assessed by gas-chromatography (n = 3). In one furth
GCDCA
Bile salt bound to mitochondria 5.81 µmol/g
Bile salt bound to mitochondrial subpopulations [μmol/g] F3D 0.49
Bile salt bound to mitochondrial subpopulations [%] F3D 0.04interaction between the responsible bile salts and the mitochondrial
membranes occurs. We therefore asked whether the bile salts GCDCA,
TCDCA, and TUDCAdiffer in their binding ability tomitochondrialmem-
branes. Mitochondrial suspensions were incubated with equal doses ofer analysis mitochondrial bound bile salts were determined after ZE-FFE.
TCDCA TUDCA
1.11% 11.88 µmol/g 0.87% 1.52 µmol/g 0.48%
F3E-III 1.68 F3B n.d.
F3E-II 0.91
F3E-I 0.47
F3E-III 0.13 F3B n.d.
F3E-II 0.07
F3E-I 0.04
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bile salts was determined by gas chromatography (Table 1).
TUDCA barely binds to mitochondria, in contrast to GCDCA and
TCDCA (Table 1). As TUDCA does neither induce MMP loss (not
shown) nor the MPT (Figs. 1, 3B), these ﬁndings underline that a
sufﬁciently strong mitochondrial binding of bile salts has to occur in
order to elicit the deleterious events.
Interestingly, a two-fold higher amount of tightly bound TCDCA is
detected when compared to GCDCA (Table 1). This ﬁnding is at ﬁrst
sight in contradiction with the observed higher mitochondrio-toxicity
of GCDCA compared to TCDCA (Fig. 1). However, an analysis of the mi-
tochondrial subpopulations that emerge upon bile salt exposure shows
that the more the outer mitochondrial membrane is stripped of, the
less bile salt can be detected in the remnant structures (Table 1). In-
deed, GCDCA and TCDCA challenged mitochondria show massive
outer membrane losses (Fig. 3) in the following order: GCDCAanodal
(Fig. 3D) > TCDCAanodal (Fig. 3E-I) > TCDCAshoulder peak (Fig. 3E-II) >
TCDCAcathodal (Fig. 3E-III). In this order the amounts of bound bile salts in-
crease (Table 1), the GCDCAanodal (Fig. 3D) and TCDCAanodal (Fig. 3E-I)
populations showing the lowest amount of boundbile salt. It thus appears
that the reason for the detected lower amount of tightly bound GCDCA
compared to TCDCA reﬂects the lower outer membrane content of the
resulting IMVs. This, however, means that themitochondrial outer mem-
brane is the major target site for bile salts.
As toxic bile salts deplete the MMP and elicit the MPT, a further
deleterious step subsequent to outer membrane binding must occur.
This step has to disrupt the inner mitochondrial membrane integrity,
which, by deﬁnition, is the unequivocal starting event for the MPT [5].
We therefore aimed at identifying the mitochondrial targets for bile
salts, which are involved in the induction of the MPT. For this purpose,
we employed a test system using dye-loaded (4-MUP) liposomes
(Fig. 5). This molecular deﬁned test system combines a sensitive detec-
tion system for the membrane permeabilising properties of bile salts
with the possibility to speciﬁcally integrate candidate bile salt target
molecules. To that end, we incorporated the isolated and puriﬁedmito-
chondrial inner membrane protein ANT or outer membrane protein
VDAC, respectively (termed ANT/VDAC-proteoliposomes).
Non-physiologically high concentrations (2 mM)of cell toxic bile salts
are required to release a signiﬁcant but low amount of 4-MUP from pure
liposomes (Fig. 5A Lipo). In contrast, in ANT-proteoliposomes, a slight dye
release can already be detected at 250 μM TCDCA or 500 μM GCDCA,
and becomes highly signiﬁcant at 1000 μM (Fig. 5A, ANT). As the
sensitivity towards cell-toxic bile salts is comparable between ANT-
proteoliposomes and whole mitochondria (Figs. 1–4), this result
suggests that the ANT protein is a target structure for cell-toxic bile
salts. Moreover TUDCA, which has no effect on mitochondria, is
also without effect on ANT-proteoliposomes (Fig. 5B).
Interestingly, VDAC-proteoliposomes also show a dose dependent
dye release upon GCDCA or TCDCA challenge, which was, especially in
the concentration range of 250–1000 μM, similar to ﬂuorescence
values obtained for ANT-proteoliposomes (Fig. 5 VDAC). This implies
that integral membrane proteins have the general potential to mediate
the toxicity of bile salts. It should be noted, however, that the total dye
load of the VDAC-proteoliposomes almost doubled the 4-MUP content
of ANT-proteoliposomes (Fig. S4A). It therefore appears that ANT
proteoliposomes are more sensitive towards bile salts compared to
VDAC-proteoliposomes. In addition, the higher the liposomal content
of ANT is, the higher the sensitivity towards TCDCA and GCDCA
(Fig. 5B). Thus, distinctive membrane proteins appear to bemore sensi-
tive towards bile salts than others and the ANT protein appears to be
one crucial mediator for bile salt mitochondrio-toxicity.
5. Discussion
In this study, we demonstrate that the bile salts GCDCA and TCDCA
have the toxic potential to directly destroy liver mitochondria. GCDCAand TCDCA induce the mitochondrial permeability transition (MPT) in a
dose dependent fashion with GCDCA being more mitochondrio-toxic
than TCDCA (Fig. 1, Fig. S1), which is in line with the established major
hepatocellular toxicity of GCDCA over TCDCA in cells and whole-organ
models [20,51]. In addition we conﬁrmed the non-toxicity of TUDCA
(500 μM) at the level of isolated mitochondria (Fig. 1, [52]). Moreover,
in preliminary studies, we observe that co-incubation of TUDCA/GCDCA
in 1:1 ratios does not prevent/delay the loss of the inner membrane po-
tential (MMP) in liver mitochondria (data not shown). This ﬁnding
agrees well with Güldütuna et al., who have reported a partial, only time-
ly restricted protective effect on mitochondria by ursodeoxycholate but
not by TUDCA [52]. Although the bile salt induced MPT can be massively
accelerated by calcium, it differsmechanistically from this prototypeMPT
inducer, as shown by differential pharmacological interventions (Fig. 1).
Calcium induced MPT occurs simultaneously to the loss of the MMP
(Fig. 2). In contrast, MMP-loss is delayed upon bile salt exposure
(Fig. 2) but preceded by massive mitochondrial structure alterations,
especially at the inner boundary membrane and the mitochondrial
cristae (Fig. 3). We have uncovered these consecutive stages of mito-
chondrial destruction by bile salts (Fig. 4). In the ﬁnal phase, MMP loss
and MPT are induced, as a consequence of the bile salt attack on integral
membrane proteins (Fig. 5) with the ANT as a critical target (Fig. 5).
5.1. The relevance of bile salt induced mitochondrial destruction in
cholestasis
How do these ﬁndings relate to pathological in vivo situations?
Typically, physiological concentrations of bile salts in hepatocytes
are low (around 1–2 μM, [53]). In cholestasis, however, a tremendous
intra-hepatocyte increase in GCDCA and TCDCA concentrations
occurs. Under these conditions, intracellular bile salt concentrations
reaching 800 μM have been reported [45,46], and 8–10% of the intra-
cellular accumulating bile salts “tightly bind” to mitochondria [54,55].
Due to the planar/disk shaped structure of bile salts, there is a general
consensus that these molecules lie ﬂat at membrane interfaces and, in
contrast to e.g., phospholipids or cholesterol, not perpendicular to the in-
terface (e.g., [56,57]). However, resulting from molecular interactions,
e.g. with polar head groups of phospholipids, their orientation within
the membrane may subsequently change ([57], and references therein,
[58]). A prerequisite for both, the sustained presence aswell as the orien-
tation alterations of bile salts, is their sufﬁciently strong binding to and/or
interaction with the membrane, which is governed by the hydrophobic
face of the bile salt steroid structure, ionic interactions and hydrogen
bonding (see below, [57]). Here, we therefore use the term “tightly
bind” to emphasize this sustained presence, which resists subsequent
mitochondrial washing/pelleting steps. This term also refers to ﬁndings
of Strange et al., who reported, by dilution studies, that a profound part
of mitochondrial bound bile salts is not readily releasable, i.e., tightly
bound [55].
Assuming an equal distribution in a hepatocyte volume of
3.4 × 10−9 ml [59], an estimated amount of one thousand mitochon-
dria per hepatocyte [60] and a protein content of roughly 1 mg for
1010 livermitochondria [61], an intra-hepatocyte bile salt concentration
of 800 μMmeans an in vivo challenge of 2–3 nmol bile salts per mg of
liver mitochondrial protein. In our in vitro settings, we have exposed
isolated rat liver mitochondria to concentrations ranging from 125 to
500 μMbile salts, equivalent to doses of 333–1333 nmol/mgmitochon-
drial protein, respectively. This is, at ﬁrst sight, a signiﬁcantly higher
challenge as the estimated 2–3 nmol/mg that would occur in vivo.
However, aswe have determined by gas chromatography, in our exper-
imental in vitro setting only a very small amount (below 1%) of these
bile salts bind strongly enough to mitochondria not to be immediately
washed away (Table 1). And it is reasonable to assume that it is this
tightly binding amount of bile salts that is responsible for the observed
strong mitochondrial membrane alterations such as the displacement
of the inner boundary membrane (Figs. 3, 4) or the MPT (Figs. 1–3). In
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to mitochondria (Table 1) and does not induce the MPT (Fig. 1, 3B).
Thus, with respect to the tightly binding bile salts, TCDCA binding efﬁ-
ciency was the highest with 0.89% (Table 1). Taking some further bile
salt losses due to outer membrane removal into account, we there-
fore estimate that, in our experimental setting, roughly 1% of the
exposed bile salts bind tightly enough to elicit a subsequent mitochon-
drial impairment. This would correspond to an in vitro challenge of
3.3–13.3 nmol tightly binding bile salts per mg mitochondrial protein,
and is only slightly higher but in the order of magnitude of the above
estimated values for the in vivo conditions. In fact, exposing susceptible
hepatocytes to bile salts result within hours in mitochondrial structurealterations, MMP loss and cell death initiation (unpublished observations
and Ref. [43]) highly similar to those ﬁndingswith isolatedmitochondria.
Thus, the chosen conditions in our study correlate with the conditions
observed in pathological cholestasis situations in hepatocytes.
5.2. The sequence of mitochondrial destruction by bile salts
How do bile salts change the mitochondrial membrane structure
culminating in elicit of the MPT? Using ZE-FFE deﬂection, electron
micrographs and immuno-blotting, we noticed that the more the mi-
tochondria lose their outer membrane, the less amounts of bile salts
can be detected in their remnant structures (Fig. 3 and Table 1).
2131S. Schulz et al. / Biochimica et Biophysica Acta 1828 (2013) 2121–2133Therefore, the outer mitochondrial membrane appears to be the crucial
and major target for bile salts. Here, the structural similarities of bile
salts to another steroid-bearing detergent, digitonin, are intriguing. It
has been known for a long time that digitonin is able to selectively dis-
mantle the outermitochondrialmembranewhich results in intact inner
membrane vesicles (IMVs) [62,63]. Thus, both steroid-bearing deter-
gents, bile salts and digitonin, attack themitochondrial outermembrane.
Moreover, mitochondria treated by digitonin also show “ﬁnger-like
extensions” of the inner membrane [63,64], similar to the inner mem-
brane structures that we observed upon TCDCA challenge (Fig. 4III, IV
and VI). As suggested by Hackenbrock and Miller [64], such extensions
form when the outer and inner mitochondrial membranes largely
detach but still have residual contacts between them. Indeed, the se-
quence of the inner mitochondrial membrane changes starting from
controls to 10 min TCDCA treatment are congruent with this scenar-
io (Fig. 4II→ IV→ VI). It thus appears that the tight binding of the bile
salts to the outer membrane together with their detergent properties
causes a massive detachment of the outer and inner (boundary) mem-
branes (Fig. 4IV and VI).
How do bile salts cause the removal of the outer membrane? In
clear contrast to the above discussed similarities to the digitonin in-
duced structure alterations, TCDCA treated mitochondria still possess
a largely intact outer membrane at the early time points (Fig. 4IV and
VI). Upondigitonin exposure, however, the outermembrane is immedi-
ately removed and only small leftovers remain at the distal ends of the
inner membrane extensions [64]. We did not observe such residual
outer membrane vesicles in bile salt treated mitochondria (Figs. 3, 4
and S3). Rather the IMVs resulting from bile salt exposure present the
picture of a full blown MOMP, highly similar to the IMVs resulting
from the calcium induced MPT (Figs. 3, 4 and S3). Moreover, the occur-
rence of these IMVs is paralleled by anMMP-loss (Fig. 2D), a clear indi-
cation of the MPT [1,5]. On the contrary, the digitonin treated
mitochondria of the above studies did not show inner membrane im-
pairments and even their coupling between MMP and oxidative phos-
phorylation remained to some extent intact [63]. Therefore, although
bile salts tightly bind to the outermembrane and provoke a detachment
of the inner boundary membrane and cristae alterations, they do not
simply dissolve the outer membrane like digitonin does, but they do in-
duce theMPT. This, however,means that the bile salts cannot exclusively
locate to the outer membrane, as they have to attack the inner mem-
brane, since the MPT is primarily an inner membrane event [5]. In line
with this prediction, a small but detectable amount of bile salts was
still present in IMVs resulting upon bile salt exposure (Table 1). For
example, upon a 500 μM GCDCA treatment, the resulting IMVs do not
possess a residual outermembrane (Fig. 3D, 3F) but a remainder of tightly
bound bile salts (Table 1). It therefore appears that, under the chosen bile
salt concentrations, it is the MPT which causes the outer membrane
removal via MOMP and not a dissolving detergent/digitonin-like effect
on the outer membrane.
5.3. The mitochondrial target structures of bile salts
What are the targets for bile salts to induce MPT? Bile salts initially
detach the inner boundary membrane from the outer membrane
(Figs. 3, 4). However, many punctuate contacts between the outer
and the inner membranes remain (Figs. 3E-III, 4III, VI). As the major
part of bile salts locates to the outer membrane and only small parts
to the inner membrane (Table 1), it is at these remaining contacts
where the inner membrane is most closely confronted with the high
bile salt amounts in the outer membrane. Thus, it is likely that the
inner membrane is permeabilized in these regions. Although there is a
continuous debate about the molecular composition of such contacts
between mitochondrial outer and inner membranes, there is good
agreement that they are speciﬁcally enriched in VDAC and ANT
[65–68]. We have therefore tested the speciﬁc sensitivity of ANT and
VDAC towards bile salts. Both proteins were puriﬁed and incorporatedinto dye-loaded liposomes of identical phospholipid composition
(Figs. 5A, S4A). While, at this point, this approach neglects the speciﬁc
presence of cholesterol and cardiolipin in the mitochondrial outer and
innermembranes, respectively, we have chosen this identical phospho-
lipid composition for the reconstituted proteoliposomes in order to
focus the experimental differences here on the embedded membrane
proteins (see also below). As detected by a signiﬁcantly higher dye
release, a pronounced membrane permeabilization occurred upon
bile salt challenges in these proteoliposomes in comparison to
phosphatidylcholine-liposomes (Fig. 5A). Thus, membrane proteins
are the likely mediators of the bile salt elicited MPT. Both ANT- and
VDAC-proteoliposomes released similar dye amounts, but the total
dye load of the VDAC-proteoliposomes almost doubled the 4-MUP
content of ANT-proteoliposomes (Fig. S4A). These results suggest that
ANT-proteoliposomes are more sensitive towards bile salts compared
to VDAC-proteoliposomes. Moreover, in ANT-proteoliposomes, a slight
dye release can already be detected at 250 μM TCDCA or 500 μM
GCDCA, and becomes highly signiﬁcant at 1000 μM (Fig. 5A, ANT).
TUDCA, which has no effect on mitochondria, is also without effect on
ANT-proteoliposomes (Fig. 5B). Finally, upon a threefold enrichment
of the liposomal ANT-content these proteoliposomes were even
more sensitive towards GCDCA and TCDCA if directly compared to
proteoliposomes with lower ANT content (Fig. 5B). Therefore ANT is
one crucial executor for bile salt derived destruction.
As mentioned, these results were obtained from proteoliposomes,
neither with implemented cholesterol, which is mainly present in the
outer membrane, nor cardiolipin, an inner membrane lipid class.
Interestingly, in ﬁrst attempts to mimic the outer membrane lipid
composition more closely (i.e. by implementation of cholesterol),
we have found, upon bile salt challenges, tendencies towards a
destabilization on VDAC-proteoliposomes and a stabilization of
ANT-proteoliposomes, respectively (data not shown). Moreover,
Lieser et al. [69] have reported an increase in the mitochondrial
cardiolipin content as a protective/adaptive mechanism to resist cell
death elicit in cholestasis. Taken together, these data clearly indicate
that the respective lipids affect the bile salt provoked vulnerability of
the mitochondrial membranes. However, such modiﬁed mitochondria
or proteoliposomes still undergo a bile salt induced membrane perme-
abilization, althoughwith altered kinetics. It therefore appears plausible
that cholesterol and cardiolipin may modify the mitochondrial mem-
brane vulnerability towards bile salts, not contradictory to the herein
reported ANT as major target for bile salts. As ANT is a highly abundant
inner membrane protein, it may present the “tip of the iceberg” of
further bile salt targets in mitochondria.
A further issue to consider from our results in future research is the
question how the bile salts pass from the outer to the innermitochondri-
al membrane to execute MPT induction. On the one hand, mitochondrial
bound bile salt may migrate within the membrane, potentially using
mitochondrial contact sites as entrance to the inner membrane. On the
other hand, bile salts may “hi-jack” mitochondrial transfer processes
and/or carriers for steroids to direct bile salts to the inner membrane. A
tempting yet speculative candidate is the mitochondrial benzodiazepine
receptor (TSPO). TSPO locates preferentially at themitochondrial contact
site and physiologically delivers cholesterol from the cytosol to the inner
membrane (Ref. [70] and references therein). Thereto TSPO possesses a
cholesterol recognition amino acid consensus (CRAC) domain in its
cytosol-located C-terminus [71,72], which may be accessible for bile
salts as well. Moreover, in silico, we determined such potential CRAC
motives in rat ANT (isoform 2, amino acids 128–138, 161–171, 226–235
and 287–296), which would mainly reside in the ANT inner transmem-
brane parts [73]. It will be interesting to see whether this route is
employed by bile salts to attack the inner membrane.
Finally, how do bile salts exert their deleterious action on mitochon-
drial membranes? As discussed above, bile salts tightly bind to biological
membranes and due to interacting forces with lipids or proteins their
orientation may change (recently reviewed in Refs. [57,58]). This
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mitochondrial membranes. In fact, recent atomic force microscopy
(AFM) imaging studies have shown that the addition of bile salts to
phospholipid monolayers disrupts their phase behavior and effectively
“solubilises” liquid condensed domains into liquid expanded regions
[57,74]. AFM has further demonstrated the capability of bile salts to
displace proteins from oil–water interfaces or collapse protein networks
[57,75]. Especially an integrity loss of the highly organized protein
network of the mitochondrial inner membrane, exempliﬁed by our
results on ANT-proteoliposomes, may inevitably lead toMPT. These ﬁnd-
ings and considerations strongly point out at the “alternative”mechanis-
tic model for the bile salt evoked MPT [12]. This model suggests that the
innermembrane is permeabilized bymisfoldings/deteriorations of native
membrane proteins which forces aqueous channels to be built.
6. Conclusion
Weﬁnd that the extent of bile salt inducedmitochondrial impairment
is bile salt species-, dose- and time-dependent. Especially at early time
points of exposure we observed only a partial Cyt C loss (Fig. 4 VI), but
an intact MMP (Fig. 2D), whereas at later time points or at high bile salt
concentrations MMP-loss and MPT massively destroy mitochondria.
This sequential mitochondrial destruction provides a strong explanation
for the clinically observed switch from apoptosis to necrosis in conse-
quence to elevated doses of bile salts [23,76,77]. It suggests that hepato-
cytes that have to face short-term or low-dose bile salt burdens may
undergo apoptosis due to a limited mitochondrial impairment. On the
contrary, a long-termormassive bile salt stress, especially in the presence
of elevated calcium levels, causes irreversible mitochondrial destructions
which may lead to necrosis. It is noteworthy that cell-toxic bile salts
do also elicit the MPT, although delayed, when their MMP has been
destroyed by FCCP (Figs. 1, S2E, F, S3D). This suggests that severe mi-
tochondrial damages can occur at later stages, well beyond the acute
phase of cholestasis and it implies that measures against this mito-
chondrial destruction should intervene at the earliest possible step.
From a pharmacological perspective, it is the binding of bile salts to
mitochondria that needs to be avoided.
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